Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): New aspects of a well-established drug

Antiviral Research

Volumn 32, Issue 1, 1996, Pages 43-53

  Weiss, Ludwig ^a   Hildt, Eberhard ^a   Hofschneider, Peter Hans ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Hepatitis B virus (HBV); Hepatitis B virus surface antigen; Interferon; N acetyl cysteine (NAC)

Indexed keywords

ACETYLCYSTEINE; INTERFERON; PARACETAMOL;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VIRUS ASSEMBLY; VIRUS INHIBITION; VIRUS REPLICATION;

HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030222246     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00977-9     Document Type: Article

References (23)

1. Beasley, R.P. and Hwang, L.Y. (1991) In: F.B. Hollinger, S.M. Lemon and M. Margolis (Eds), Viral Hepatitis and Liver Diseases, pp. 532-535. Williams and Wilkins, Baltimore, MD.
2. Beloqui, O., Prieto, J., Subárez, M., Gil, B., Quian, C.H., Garcia, N. and Civera, M.P. (1993) N-Acetyl cysteine enhances the response to interferon-α in chronic hepatitis C: a pilot study. J. Interferon Res. 13, 279-282.
3. Ganem, D. and Varmus, H.E. (1987) The molecular biology of the hepatitis B viruses. Ann. Rev. Biochem. 56, 651-693.
4. Gavish, D. and Breslow, J.L. (1991). Lipoprotein (a) reduction by N-acetylcysteine. Lancet 337, 203-204.
5. Gorman, C., Moffat, L. and Howard, B. (1982) Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol. Cell. Biol. 2, 1044-1051.
6. Graham, F.L. and van der Eb, A.J. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
7. Hirt, B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369.
8. Huovila, A.P.J., Eder, M.A. and Fuller, S. (1992) Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J. Cell. Biol. 118, 1305-1320.
9. Kalebic, T., Kinter, A., Poli, G., Anderson, M.E., Meister, A. and Fauci, A. (1991). Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester and N-acetylcysteine. Proc. Natl. Acad. Sci. USA 88, 986-990.
10. Kaplan, P.M., Greenman, R.L., Gerin, J.L., Purcell, R.H. and Robinson, W.S. (1973) DNA-Polymerase associated with human hepatitis B antigen. J. Virol. 12, 955-1005.
11. 1: activation of NF-κB, selective inhibition by antioxidants and integral membrane localization. EMBO J. 11, 2991-3001.
12. Miller, L.F. and Rumack, B.H. (1983) Clinical safety of oral doses of acetylcysteine. Semin. Oncol. 10, 76-85.
13. Nabel, G. and Baltimore, D. (1987) An inducable transcription factor activates expression of human immunodeficiency virus in T-cells. Nature 326, 711-713.
14. Olsson, B., Johansson, M., Gabrielson, J. and Bolme, P. (1988) Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur. J. Clin. Pharmacol. 34, 77-82.
15. Perrillo, R.P.. Schiff, E.R.. Gray, L.D., Bodenheimer, H.C., Lindsay, K., Payne, J., Dienstag, J.L., O'Brien, C., Tamburro, C., Jacobson. I.M., Sampliner, R., Feit, D., Lefkowitch, J., Kuhns, M., Meschievts, C., Sanghvi, B., Albrecht, J., Gibas, A. and The Hepatitis International Therapy Group (1990) A randomized, controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N. Engl. J. Med. 323, 295-301.
16. Radziwill, G., Zentgraf, H., Schaller, H. and Bosch, V. (1988) The duck hepatitis B virus DNA polymerase is tightly associated with the viral core structure and unable to switch to an exogenous template. Virology 163, 123-132.
17. Roederer, M., Staal, F.J.T., Raju, P.A., Ela, S.W., Herzenberg, L.A. and Herzenberg, L.A. (1990) Cytokine stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc. Natl. Acad. Sci. USA 87, 4884-4888.
18. Schreck, R. and Baeuerle. P.A. (1991) A role of oxygen radicals as second messengers. Trends Cell. Biol. 1, 39-42.
19. Schreck, R., Grassmann, R.. Fleckenstein, B. and Baeuerle. P.A. (1992) Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type I tax protein. J. Virol. 66, 6288-6293.
20. Sells, M.A., Chen, M.L. and Acs, G. (1987) Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84, 1005-1009.
21. Smilkstein M.J.. Gary. M.D., Knapp, M.S., Kenneth, W., Kulig, M.D. and Rumack, M.D. (1988). Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. J. Med. 24, 1557-1562.
22. Vyas, G.N., Rao, K.R. and Ibrahim, A. (1972) Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science 178, 1300-1301.
23. Weiss, L., Kekulè, A.S.. Jakubowski, U.. Bürgelt, E. and Hofschneider, P.H. (1996) The HBV-producing cell line HepG2-4A5: A new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs. Virology 216, 214-218.